Feasibility Study on the Use of Redormin®500 on Day-time Cognition
Sleep Disorders, Circadian Rhythm, Cognitive Dysfunction
About this trial
This is an interventional other trial for Sleep Disorders, Circadian Rhythm
Eligibility Criteria
Inclusion Criteria: Healthy Male or female Age: 18-65 years old Occasional sleep problems (in average 1-2 nights per week, PSQI-score >5) with accompanying subjective cognitive problems (in average at least on one day per week) in the last month Fluent in German Able and willing to give written informed consent and comply with the requirements of the study protocol Exclusion Criteria: DSM-V diagnosis of insomnia History of neurologic disorder Current psychiatric disorder Presence of moderately severe or severe depressive disorder (PHQ-9 ≥ 15) Current chronic intake of prescription drugs with psychotropic effects Current intake of OTC drugs for sleep or mood problems Presence of pain condition Diabetes mellitus Coronary Heart Disease
Sites / Locations
- Research Platform MCN University of BaselRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Redormin® 500
Placebo
fixed combination of valerian and hops dry extract, 500 mg, once daily for 21 days
matching placebo, once daily for 21 days